Nasdaq or NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of August 2026

Nasdaq or NYSE listed Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Largest Companies List by Market Cap as of August 2026

  1. Relay Therapeutics Inc.

    World Rank (Aug-2026)
    3,970
    Market Cap (Aug-2026)
    4.352 Billion USD
    World Rank (Jan-05-2024)
    6,953
    Market Cap (Jan-05-2024)
    1.434 Billion USD
    World Rank (Jul-30-2023)
    6,911
    Market Cap (Jul-30-2023)
    1.487 Billion USD
    World Rank (Dec-25-2022)
    5,890
    Market Cap (Dec-25-2022)
    1.765 Billion USD
    World Rank (Jan-07-2022)
    4,967
    Market Cap (Jan-07-2022)
    2.90 Billion USD
    Annual Revenue in USD
    15 Million USD
    Annual Operating Income in USD
    -303 Million USD
    Annual Net Income in USD
    -276 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Relay Therapeutics is a Biotechnology company related to Clinical Stage Precision Medicine company focused on transforming the drug discovery process. The company estimated annual revenue is currently 22 million per year and 122 employees as on 2019. The headquarters is in USA.
    Company Website
    RELAY THERAPEUTICS, INC.

  2. Adaptive Biotechnologies Corporation

    World Rank (Aug-2026)
    4,223
    Market Cap (Aug-2026)
    3.948 Billion USD
    World Rank (Jan-05-2024)
    10,807
    Market Cap (Jan-05-2024)
    0.673 Billion USD
    World Rank (Jul-30-2023)
    7,981
    Market Cap (Jul-30-2023)
    1.165 Billion USD
    World Rank (Dec-25-2022)
    8,035
    Market Cap (Dec-25-2022)
    1.073 Billion USD
    World Rank (Jan-07-2022)
    4,537
    Market Cap (Jan-07-2022)
    3.27 Billion USD
    Annual Revenue in USD
    277 Million USD
    Annual Operating Income in USD
    -57 Million USD
    Annual Net Income in USD
    -59 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Adaptive Biotechnologies Corporation is a Life Science Equipment and Technology company. The company products and services of both current and pipeline, supporting life sciences research, clinical diagnostics and drug discovery, aim is to add an entirely new dimension to the diagnosis and treatment of disease from cancer to autoimmune conditions to infectious diseases. The headquarters is in USA.

    Company Website
    ADAPTIVE BIOTECHNOLOGIES CORPORATION

  3. Denali Therapeutics

    World Rank (Aug-2026)
    4,250
    Market Cap (Aug-2026)
    3.900 Billion USD
    World Rank (Jan-05-2024)
    4,587
    Market Cap (Jan-05-2024)
    2.812 Billion USD
    World Rank (Jul-30-2023)
    3,643
    Market Cap (Jul-30-2023)
    3.830 Billion USD
    World Rank (Dec-25-2022)
    3,453
    Market Cap (Dec-25-2022)
    3.785 Billion USD
    World Rank (Jan-07-2022)
    3,242
    Market Cap (Jan-07-2022)
    5.08 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Operating Income in USD
    -555 Million USD
    Annual Net Income in USD
    -513 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Denali Therapeutics is a Biotechnology company focused on Neurodegenerative Diseases. The headquarters is in USA.

    Company Website
    DENALI THERAPEUTICS INC

  4. Iovance Biotherapeutics

    World Rank (Aug-2026)
    4,887
    Market Cap (Aug-2026)
    3.162 Billion USD
    World Rank (Jan-05-2024)
    5,548
    Market Cap (Jan-05-2024)
    2.075 Billion USD
    World Rank (Jul-30-2023)
    6,175
    Market Cap (Jul-30-2023)
    1.782 Billion USD
    World Rank (Dec-25-2022)
    8,549
    Market Cap (Dec-25-2022)
    0.966 Billion USD
    World Rank (Jan-07-2022)
    5,413
    Market Cap (Jan-07-2022)
    2.55 Billion USD
    Annual Revenue in USD
    264 Million USD
    Annual Operating Income in USD
    -403 Million USD
    Annual Net Income in USD
    -391 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Iovance Biotherapeutics is a development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes company. The headquarters is in USA.
    Company Website
    IOVANCE BIOTHERAPEUTICS INC

  5. Beam Therapeutics Inc.

    World Rank (Aug-2026)
    5,282
    Market Cap (Aug-2026)
    2.763 Billion USD
    World Rank (Jan-05-2024)
    5,482
    Market Cap (Jan-05-2024)
    2.121 Billion USD
    World Rank (Jul-30-2023)
    5,105
    Market Cap (Jul-30-2023)
    2.392 Billion USD
    World Rank (Dec-25-2022)
    4,254
    Market Cap (Dec-25-2022)
    2.844 Billion USD
    World Rank (Jan-07-2022)
    3,394
    Market Cap (Jan-07-2022)
    4.79 Billion USD
    Annual Revenue in USD
    140 Million USD
    Annual Operating Income in USD
    -384 Million USD
    Annual Net Income in USD
    -80 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Company Profile

    Beam Therapeutics is a Biotechnology company developing precision genetic medicines through the use of base editing. The headquarters is in USA.

    Facts About Company

    The company annual revenue is 60 million USD and net loss was -289 million USD as on Dec-2022.

    Company Website
    BEAM THERAPEUTICS INC.

  6. Kodiak Sciences

    World Rank (Aug-2026)
    5,488
    Market Cap (Aug-2026)
    2.588 Billion USD
    World Rank (Jan-05-2024)
    19,085
    Market Cap (Jan-05-2024)
    0.160 Billion USD
    World Rank (Jul-30-2023)
    19,561
    Market Cap (Jul-30-2023)
    0.150 Billion USD
    World Rank (Dec-25-2022)
    14,429
    Market Cap (Dec-25-2022)
    0.368 Billion USD
    World Rank (Jan-07-2022)
    4,108
    Market Cap (Jan-07-2022)
    3.74 Billion USD
    Annual Operating Income in USD
    -234 Million USD
    Annual Net Income in USD
    -230 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile

    Kodiak Sciences is a Clinical Stage Biopharmaceutical company. It is specializing in novel therapeutics to treat chronic and high prevalence ophthalmic diseases. The headquarters is in USA.

    Company Website
    KODIAK SCIENCES

  7. BioCryst Pharmaceuticals

    World Rank (Aug-2026)
    5,615
    Market Cap (Aug-2026)
    2.489 Billion USD
    World Rank (Jan-05-2024)
    7,310
    Market Cap (Jan-05-2024)
    1.323 Billion USD
    World Rank (Jul-30-2023)
    7,021
    Market Cap (Jul-30-2023)
    1.451 Billion USD
    World Rank (Dec-25-2022)
    5,228
    Market Cap (Dec-25-2022)
    2.135 Billion USD
    World Rank (Jan-07-2022)
    6,134
    Market Cap (Jan-07-2022)
    2.08 Billion USD
    Annual Revenue in USD
    875 Million USD
    Annual Operating Income in USD
    341 Million USD
    Annual Net Income in USD
    264 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Frankfurt
    Company Profile
    BioCryst Pharmaceuticals is a Biotechnology company designs and develops small molecule medicines for rare diseases like hereditary angioedema (HAE) and fibrodysplasia ossificans progressive (FOP). The company annual revenue is 49 million USD and 140 employees as on 2019. The headquarters is in USA.
    Company Website
    BIOCRYST PHARMACEUTICALS
    Wikipedia
    Wikipedia

  8. Vericel Corporation

    World Rank (Aug-2026)
    5,928
    Market Cap (Aug-2026)
    2.263 Billion USD
    World Rank (Jan-05-2024)
    6,459
    Market Cap (Jan-05-2024)
    1.623 Billion USD
    World Rank (Jul-30-2023)
    6,143
    Market Cap (Jul-30-2023)
    1.797 Billion USD
    World Rank (Dec-25-2022)
    7,816
    Market Cap (Dec-25-2022)
    1.125 Billion USD
    World Rank (Jan-07-2022)
    6,909
    Market Cap (Jan-07-2022)
    1.71 Billion USD
    Annual Revenue in USD
    276 Million USD
    Annual Operating Income in USD
    11 Million USD
    Annual Net Income in USD
    17 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Bio pharmaceutical company with headquarters is in USA.
    Company Website
    VERICEL

  9. ADMA Biologics

    World Rank (Aug-2026)
    6,140
    Market Cap (Aug-2026)
    2.121 Billion USD
    World Rank (Jan-05-2024)
    8,463
    Market Cap (Jan-05-2024)
    1.024 Billion USD
    World Rank (Jul-30-2023)
    9,311
    Market Cap (Jul-30-2023)
    0.896 Billion USD
    World Rank (Dec-25-2022)
    9,556
    Market Cap (Dec-25-2022)
    0.806 Billion USD
    World Rank (Jan-07-2022)
    17,664
    Market Cap (Jan-07-2022)
    0.26 Billion USD
    Annual Revenue in USD
    510 Million USD
    Annual Operating Income in USD
    191 Million USD
    Annual Net Income in USD
    147 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Website
    ADMA BIOLOGICS

  10. Immunocore Holdings PLC

    World Rank (Aug-2026)
    7,095
    Market Cap (Aug-2026)
    1.645 Billion USD
    World Rank (Jan-05-2024)
    4,182
    Market Cap (Jan-05-2024)
    3.200 Billion USD
    World Rank (Jul-30-2023)
    4,317
    Market Cap (Jul-30-2023)
    3.041 Billion USD
    World Rank (Dec-25-2022)
    4,355
    Market Cap (Dec-25-2022)
    2.769 Billion USD
    World Rank (Jan-07-2022)
    8,234
    Market Cap (Jan-07-2022)
    1.26 Billion USD
    Annual Revenue in USD
    31 Million USD
    Annual Net Income in USD
    -154 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    UK
    Stock Category
    UK ADRs
    Yahoo @ Nasdaq
    Company Profile

    Immunocore is a pioneering, clinical-stage T cell receptor biotechnology company working to develop and commercialize a new generation of transformative medicines to address unmet needs in cancer, infection and autoimmune disease. Headquarters is in UK.

    Company Website
    IMMUNOCORE HOLDINGS PLC

Share